Consistently, OMP-52M51 inhibited the DLL4-induced MYC and NPM1 (p < 0.05), and tended to reduce CCND1 gene expression, specifically in CLL cells carrying NOTCH1 mutation (Fig. 4b). This evidence concerns the gene MYC and B-cell chronic lymphocytic leukemia.